Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Veracyte Inc
Veracyte Inc logo

VCYT - Veracyte Inc Share News

$52.9 2.1  4.2%

Last Trade - 6:25pm

Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
Momentum Trap
Market Cap £2.16bn
Enterprise Value £1.91bn
Revenue £82.9m
Position in Universe 1727th / 6554
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions VCYT Dividends
All News
All News Reuters News Company Announcements
BUZZ-Veracyte: Up on collaboration with Bayer to advance genomic test
22nd Dec '20 News
BRIEF-Bayer And Veracyte Announce Precision Oncology Collaboration In Thyroid Cancer
22nd Dec '20 News
BRIEF-Veracyte Announces Iso 134852016 Certification For Its In Vitro Diagnostics Quality Management System
21st Dec '20 News
BRIEF-Veracyte Announces New Preliminary Data For Its In-Development Lung Cancer Portfolio Tests
16th Dec '20 News
BRIEF-Veracyte Announces Third Quarter 2020 Financial Results
2nd Nov '20 News
BRIEF-Veracyte Announces New Data Published In Journal Of Clinical Oncology Suggest The Prosigna Breast Cancer Test’S Genomic Underpinning Drives Prognostic Performance
30th Oct '20 News
BRIEF-Veracyte Publishes Manuscript On Next-Generation Percepta Genomic Sequencing Classifier
22nd Oct '20 News
BRIEF-Veracyte Reports New Data Reinforcing Foundational Technology Of Nasal Swab Test For Early Lung Cancer Detection
19th Oct '20 News
BRIEF-Veracyte Says CMS Approved New Adlt Status For Envisia Genomic Classifier
24th Sep '20 News
BRIEF-Veracyte Announces Initiation Of Consensus Study Exploring Medical Utility Of Multiple Breast Cancer Genomic Tests
11th Sep '20 News
BRIEF-Veracyte Announces Pricing Of Public Offering Of 6,000,000 Shares Of Common Stock
5th Aug '20 News
BRIEF-Veracyte Inc Files For Offering 6 Million Shares Of Common Stock - SEC Filing
3rd Aug '20 News
BRIEF-Veracyte Announces Proposed Public Offering Of Common Stock
3rd Aug '20 News
BRIEF-Veracyte Reports Q2 Loss Per Share $0.22
30th Jul '20 News
BRIEF-Veracyte and MAVIDx Announce Agreement to Develop High Volume COVID-19 Testing
29th Jul '20 News
BRIEF-Veracyte Announces De Novo Classification Request To FDA For The Ncounter Dx Lymphmark Assay
9th Jun '20 News
BRIEF-Caredx And Veracyte Announce Partnership For Transplant Rejection Testing On Ncounter System
14th May '20 News
BRIEF-Veracyte And Yale Announce Exclusive License To Advance First Genomic Monitoring Test For Idiopathic Pulmonary Fibrosis
23rd Apr '20 News
BRIEF-Veracyte Reports Prelim Q1 2020 Financial Results
16th Apr '20 News
BRIEF-Veracyte Announces Novel Gene Fusion Detection With Afirma Xpression Atlas
1st Apr '20 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.